According to a recent LinkedIn post from Strive Health, the company is using March’s National Kidney Month to highlight the scale of chronic kidney disease in the U.S., citing an estimated 37 million Americans affected and noting that many cases remain undiagnosed. The post links kidney disease to comorbid conditions such as diabetes and hypertension and emphasizes the importance of early awareness, prevention and coordinated care.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights a focus on proactive, personalized and patient-centered value-based care as a framework for improving kidney health outcomes. For investors, this emphasis suggests Strive Health is positioning its offerings around population health management and cost-containment trends in chronic disease, which could support demand for its services as payors and providers increasingly shift toward value-based models.

